Riskpilot← Back to searchSign inGet full accessGranulosa AB
ABActiveOrg 5568300304Galoppvägen 46-0Medical specialists activities · NACE 8622Est. 20103 employees
Revenue 2024
SEK 4,7M
-12% vs 2023
EBITDA margin
22.5%
-16% vs 2023
Equity ratio
55.2%
Financial strength
Net profit 2024
SEK 794K
-17% vs 2023
| Revenue | SEK 4,7M | -12% |
| EBITDA | SEK 1,1M | -16% |
| Net profit | SEK 794K | -17% |
| Total assets | SEK 2,2M | -19% |
| Equity | SEK 1,2M | -17% |
| Employees | 3 | — |
Legal name
Granulosa AB
Org number
5568300304
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 december 2010
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva hälsa- och sjukvård samt därmed förenlig verksamhet.
Address
Galoppvägen 46-0
Email
maria.wolnerhanssen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 590 | 5 746 | 5 612 | 5 369 | 4 698 |
| Staff expenses | — | — | — | — | −2 099 |
| EBITDA | 1 041 | 2 353 | 1 744 | 1 255 | 1 056 |
| Depreciation & amort. | −108 | −98 | −83 | −62 | −69 |
| EBIT | 933 | 2 255 | 1 661 | 1 193 | 987 |
| Net financials | −12 | −6 | — | 11 | 12 |
| Profit before tax | 922 | 2 248 | 1 661 | 1 205 | 999 |
| Tax | −198 | −463 | −344 | −247 | −205 |
| Net profit | 724 | 1 785 | 1 317 | 958 | 794 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 552 | 2 978 | 3 075 | 2 720 | 2 196 |
| Equity | 869 | 1 954 | 1 603 | 1 461 | 1 212 |
| Long-term debt | 47 | 0 | 0 | 0 | — |
| Short-term debt | 636 | 1 024 | 1 472 | 1 258 | 984 |
| Total debt | 683 | 1 024 | 1 472 | 1 258 | 984 |
EBITDA margin
22.5%
This company
15.8%
Market median
+42% vs market
20202024
Equity ratio
55.2%
This company
38.2%
Market median
+45% vs market
20202024
Return on equity
65.5%
This company
18.4%
Market median
+256% vs market
20202024
Net profit margin
16.9%
This company
8.1%
Market median
+109% vs market
20202024
Asset turnover
2.14×
This company
1.12×
Market median
+91% vs market
20202024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2020 | |
| Former (1) | ||
PW Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Granulosa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Henrik Alexander Brodström | Audit | 0 companies |
| Pål Wölner-Hanssen | Chief Executive Officer | 0 companies |
| Martin Petter Johannes Westin | Deputy Board Member | 0 companies |
| Maria-Dorothea Eleonora Wölner-Hanssen | Board of Directors | 0 companies |